Pharmacokinetics of Tapentadol in Subjects With Varying Degrees of Renal Impairment

被引：0
|
作者：
Smit, J. W. [1 ]
Kleideiter, E. [2 ]
Brett, M. [3 ]
Lannie, C. [1 ]
Mangold, B. [1 ]
机构：
[1] Johnson & Johnson Phamaceut Res & Dev, Div Janssen Phamaceut, Beerse, NV, Belgium
[2] Grunenthal GmbH, Global Clin Dev, Aachen, Germany
[3] Grunenthal GmbH, Global Preclin Dev, Aachen, Germany
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2010年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
95
引用
收藏
页码：1079 / 1079
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics of Tapentadol in Subjects With Varying Degrees of Hepatic Impairment
    Smit, J. W.
    Brett, M.
    Kleideiter, E.
    Lannie, C.
    Mangold, B.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1078 - 1078
  • [2] PHARMACOKINETICS OF FAMCICLOVIR IN SUBJECTS WITH VARYING DEGREES OF RENAL IMPAIRMENT
    BOIKE, SC
    PUE, MA
    FREED, MI
    AUDET, PR
    FAIRLESS, A
    ILSON, BE
    ZARIFFA, N
    JORKASKY, DK
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (04) : 418 - 426
  • [3] Pharmacokinetics of intravenous telavancin in healthy subjects with varying degrees of renal impairment
    Philip D. Worboys
    Shekman L. Wong
    Steven L. Barriere
    [J]. European Journal of Clinical Pharmacology, 2015, 71 : 707 - 714
  • [4] Pharmacokinetics of intravenous telavancin in healthy subjects with varying degrees of renal impairment
    Worboys, Philip D.
    Wong, Shekman L.
    Barriere, Steven L.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (06) : 707 - 714
  • [5] PHARMACOKINETICS OF OFLOXACIN IN HEALTHY-SUBJECTS AND PATIENTS WITH VARYING DEGREES OF RENAL IMPAIRMENT
    FLOR, S
    GUAY, D
    OPSAHL, J
    TACK, K
    MATZKE, G
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1991, 11 (03) : 115 - 121
  • [6] Safety and pharmacokinetics of SPR206 in subjects with varying degrees of renal impairment
    Bruss, Jon B.
    Bader, Justin
    Hamed, Kamal A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (11)
  • [7] Pharmacokinetics of maribavir, a novel oral anticytomegalovirus agent, in subjects with varying degrees of renal impairment
    Swan, Suzanne K.
    Smith, William B.
    Marbury, Thomas C.
    Schumacher, Mary
    Dougherty, Carolyn
    Mico, Bruce A.
    Villano, Stephen A.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (02): : 209 - 217
  • [8] NABUMETONE PHARMACOKINETICS IN PATIENTS WITH VARYING DEGREES OF RENAL IMPAIRMENT
    BOELAERT, JR
    JONNAERT, HA
    DANEELS, RF
    SCHURGERS, ML
    THAWLEY, AR
    UNDRE, NA
    COOPER, DL
    [J]. AMERICAN JOURNAL OF MEDICINE, 1987, 83 (4B): : 107 - 109
  • [9] Pharmacokinetics of vildagliptin in patients with varying degrees of renal impairment
    He, Yan-Ling
    Kulmatycki, Kenneth
    Zhang, Yiming
    Zhou, Wei
    Reynolds, Christine
    Ligueros-Saylan, Monica
    Taylor, Ann
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (09) : 693 - 703
  • [10] Pharmacokinetics of pilocarpine in subjects with varying degrees of renal function
    St Peter, JV
    Lambrecht, LJ
    Gunderson, BW
    Andersen, SA
    Gallagher, SC
    Swan, SK
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (12): : 1470 - 1475
12345